BIT
ACUR

BlackRock Institutional Trust’s Acura Pharmaceuticals ACUR Stock Holding History

BlackRock Institutional Trust’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,423
Closed -$54K – 4094
2013
Q4 		$54K Hold
6,423
– – ﹤0.01% 3849
2013
Q3 		$61K Buy
6,423
+3,773
+142% +$33.4K ﹤0.01% 3806
2013
Q2 		$25K Buy
+2,650
New +$29.9K ﹤0.01% 3867

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's ACUR Position: Q1 2014 in Review

BlackRock Institutional Trust sold out of Acura Pharmaceuticals (ACUR) in Q1 2014, closing a stake of 6,423 shares — an estimated $54K sold.

BlackRock Institutional Trust first reported a position in ACUR in Q2 2013 and held it in 3 quarters. The position peaked at $61K in Q3 2013. 37 funds tracked by Wall St. Rank hold ACUR as of Q1 2014.

  • BlackRock Institutional Trust reported no remaining Acura Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 6,423 Acura Pharmaceuticals shares in Q1 2014, an estimated $54K.
  • BlackRock Institutional Trust first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • BlackRock Institutional Trust's Acura Pharmaceuticals position peaked at $61K in Q3 2013.
  • 37 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2014.

Based on BlackRock Institutional Trust's 13F filing for Q1 2014, filed 2 May 2014.